Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany
View ORCID ProfileN. Ahmad Aziz, View ORCID ProfileVictor M Corman, Antje K.C. Echterhoff, Anja Richter, Antonio Schmandke, Marie Luisa Schmidt, Thomas H. Schmidt, Folgerdiena M De Vries, View ORCID ProfileChristian Drosten, View ORCID ProfileMonique M.B. Breteler
doi: https://doi.org/10.1101/2020.08.24.20181206
N. Ahmad Aziz
1 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE) & Department of Neurology, Faculty of Medicine, University of Bonn;
Victor M Corman
2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;
Antje K.C. Echterhoff
3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);
Anja Richter
2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;
Antonio Schmandke
3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);
Marie Luisa Schmidt
2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;
Thomas H. Schmidt
3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);
Folgerdiena M De Vries
3 Population Health Sciences, German Center for Neurodegenerative Diseases (DZNE);
Christian Drosten
2 National Consultant Laboratory for Coronaviruses, Institute of Virology, Charite - Universitätsmedizin Berlin;
Monique M.B. Breteler
4 Population Health Sciences, German Center for Neurodegenerative diseases (DZNE) & Institute for Medical Biometry, Informatics and Epidemiology (IMBIE), Faculty of Medicine, University of Bonn

Data Availability
The Rhineland Study's dataset is not publicly available because of data protection regulations. Access to data can be provided to scientists in accordance with the Rhineland Study's Data Use and Access Policy. Requests for further information or to access the Rhineland Study's dataset should be directed to RS-DUAC@dzne.de.
Posted August 29, 2020.
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany
N. Ahmad Aziz, Victor M Corman, Antje K.C. Echterhoff, Anja Richter, Antonio Schmandke, Marie Luisa Schmidt, Thomas H. Schmidt, Folgerdiena M De Vries, Christian Drosten, Monique M.B. Breteler
medRxiv 2020.08.24.20181206; doi: https://doi.org/10.1101/2020.08.24.20181206
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies: Results from a population-based study in Bonn, Germany
N. Ahmad Aziz, Victor M Corman, Antje K.C. Echterhoff, Anja Richter, Antonio Schmandke, Marie Luisa Schmidt, Thomas H. Schmidt, Folgerdiena M De Vries, Christian Drosten, Monique M.B. Breteler
medRxiv 2020.08.24.20181206; doi: https://doi.org/10.1101/2020.08.24.20181206
Subject Area
Subject Areas
- Addiction Medicine (62)
- Allergy and Immunology (142)
- Anesthesia (44)
- Cardiovascular Medicine (408)
- Dermatology (47)
- Emergency Medicine (141)
- Epidemiology (4815)
- Gastroenterology (177)
- Geriatric Medicine (70)
- Health Economics (187)
- Health Informatics (621)
- Health Policy (314)
- Hematology (85)
- HIV/AIDS (155)
- Medical Education (91)
- Medical Ethics (24)
- Nephrology (73)
- Neurology (677)
- Nursing (41)
- Nutrition (111)
- Oncology (438)
- Ophthalmology (138)
- Orthopedics (36)
- Otolaryngology (88)
- Pain Medicine (35)
- Palliative Medicine (15)
- Pathology (128)
- Pediatrics (193)
- Public and Global Health (1799)
- Radiology and Imaging (321)
- Respiratory Medicine (255)
- Rheumatology (86)
- Sports Medicine (61)
- Surgery (100)
- Toxicology (23)
- Transplantation (28)
- Urology (37)